Kiniksa Pharmaceuticals L... (KNSA)
22.46
-0.63 (-2.73%)
At close: Mar 31, 2025, 10:42 AM
Kiniksa Pharmaceuticals Ltd. Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 183.58M | 107.95M | 122.72M | 122.47M | 114.04M | 46.93M | 307.3M | 45.55M | 55.97M |
| Short-Term Investments | 60.05M | 98.42M | 67.89M | 59.73M | 209.44M | 186.45M | 235.33M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 210K | 210K | n/a | n/a |
| Other Long-Term Assets | 10.31M | 827K | 5.82M | 8.72M | 5.59M | 210K | 643K | 25K | 8K |
| Receivables | 41.72M | 21.27M | 20.32M | 3.98M | n/a | n/a | n/a | n/a | n/a |
| Inventory | 26.36M | 31.12M | 21.6M | 3.67M | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 20.08M | 17.54M | 10.54M | 13.17M | 9.77M | 16.49M | 12.89M | 1.55M | 364K |
| Total Current Assets | 331.8M | 276.3M | 243.06M | 196.45M | 333.25M | 241.63M | 313.75M | 47.1M | 56.33M |
| Property-Plant & Equipment | 11.04M | 12.66M | 7.04M | 8.38M | 10.62M | 8.32M | 6.36M | 125K | 84K |
| Goodwill & Intangibles | 16.25M | 17.25M | 18.25M | 19.25M | n/a | -210K | -210K | n/a | n/a |
| Total Long-Term Assets | 248.75M | 250.03M | 216.61M | 36.35M | 16.21M | 12.91M | 8.21M | 388K | 133K |
| Total Assets | 580.55M | 526.32M | 459.67M | 232.8M | 349.46M | 254.53M | 321.96M | 47.49M | 56.47M |
| Account Payables | 2.04M | 8.25M | 7.9M | 1.87M | 503K | 5.69M | 10.92M | 1.22M | 212K |
| Deferred Revenue | 31.81M | 307K | 12M | 38.03M | 29.2M | 20.41M | n/a | n/a | n/a |
| Short-Term Debt | 3.99M | 2.25M | 6.6M | 6.76M | 4.21M | 3.39M | n/a | n/a | n/a |
| Other Current Liabilities | 62.78M | 52.86M | 32.56M | 36.19M | 27.13M | 18.74M | 31.64M | 16.21M | 2.09M |
| Total Current Liabilities | 100.62M | 63.67M | 47.07M | 44.82M | 31.85M | 27.83M | 42.55M | 17.43M | 2.3M |
| Long-Term Debt | 7.86M | 10.01M | 2.62M | 2.67M | 4.88M | 955K | n/a | n/a | n/a |
| Other Long-Term Liabilities | 33.63M | 1.86M | 1.84M | 270K | 805K | 326K | 144K | 119.77M | 79.9M |
| Total Long-Term Liabilities | 41.5M | 23.82M | 16.46M | 2.94M | 5.68M | 1.28M | 144K | 119.77M | 79.9M |
| Total Liabilities | 142.12M | 87.48M | 63.52M | 47.76M | 37.53M | 29.11M | 42.7M | 137.2M | 82.2M |
| Total Debt | 9.86M | 12.26M | 5.92M | 6.05M | 6.99M | 2.65M | n/a | n/a | n/a |
| Common Stock | 20K | 20K | 19K | 18K | 18K | 15K | 13K | 1K | 1K |
| Retained Earnings | -521.14M | -477.95M | -492.03M | -675.4M | -517.47M | -356.09M | -194.22M | -91M | -26.13M |
| Comprehensive Income | -163K | 6K | 44K | -66K | -34K | 33K | -4K | -52K | -24K |
| Shareholders Equity | 438.44M | 438.84M | -492.03M | -675.4M | -517.47M | -356.09M | -194.22M | -89.71M | -25.73M |
| Total Investments | 60.05M | 98.42M | 67.89M | 59.73M | 209.44M | 186.45M | 235.33M | n/a | n/a |